← Back
$RCUS All transactions

Arcus Biosciences, Inc.

▼ SELL 10b5-1 Plan

$ Value

$97K

Shares

4,343

Price

$22

Filed

Dec 18

Insider

Name

Azoy Alexander

Title

Chief Accounting Officer

CIK

0001771961

Roles

Officer

Transaction Details

Transaction Date

2025-12-18

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

18,531

Footnotes

Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | Includes the unvested portion of the reporting person's RSU grants. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.90 to $22.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Filing Info

Accession No.

0001771961-25-000014

Form Type

4

Issuer CIK

0001724521

Azoy Alexander's History

Date Ticker Type Value
2026-01-23 RCUS A $0
2026-01-23 RCUS A $0
2025-12-18 RCUS $97K
2025-12-17 RCUS $47K
2025-12-16 RCUS $52K
2025-11-26 RCUS M $25K
2025-11-26 RCUS $49K
2025-11-26 RCUS M $0
2025-09-29 RCUS $37K
2025-09-05 RCUS $19K

Other Insiders at RCUS (90d)

Insider Bought Sold Last
ROSEN TERRY J
Chief Executive Officer
2026-01-23
Jaen Juan C.
President
2026-01-23
Goeltz II Robert C.
Chief Financial Officer
2026-01-23
Jarrett Jennifer
Chief Operating Officer
2026-01-23
Azoy Alexander
Chief Accounting Officer
2026-01-23
Tang Carolyn C.
General Counsel
2026-01-23
Markus Richard
Chief Medical Officer
2026-01-23